Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Government Accountability Office. Novartis Pharmaceuticals Corporation, B-285038.4; B-285038.5, February 1, 2002. B-285038.4. Washington, DC, 2002. https://www.govinfo.gov/app/details/GAOREPORTS-B-285038-4
Government Accountability Office. (2002, February 1). GAO/B-285038.4 - Novartis Pharmaceuticals Corporation, B-285038.4; B-285038.5, February 1, 2002. [Government]. U.S. Government Publishing Office. https://www.govinfo.gov/app/details/GAOREPORTS-B-285038-4
Government Accountability Office. GAO/B-285038.4 - Novartis Pharmaceuticals Corporation, B-285038.4; B-285038.5, February 1, 2002. U.S. Government Publishing Office, (1 Feb 2002), https://www.govinfo.gov/app/details/GAOREPORTS-B-285038-4
Government Accountability Office, Novartis Pharmaceuticals Corporation, B-285038.4; B-285038.5, February 1, 2002, GovInfo, (February 1, 2002), https://www.govinfo.gov/app/details/GAOREPORTS-B-285038-4